Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUDCA for Hepatobiliary Disease in Cystic Fibrosis
NCT00004441Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Sep 1997
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tauroursodeoxycholic acid in cystic fibrosis-associated liver disease (CFLD), sponsored by Cincinnati Children's Hospital Medical Center. Started Sep 1997; status: completed.
02
Drugs
tauroursodeoxycholic acid
03
Conditions
cystic fibrosis-associated liver disease (CFLD)
Beyond the preview
Go deeper on NCT00004441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004441.